CD8A and neoplasm: The tumor immunity elicited by most of the 9 TRMNs identified here is CD8+ T cell dependent, as observed by the abrogation of immunity by depletion of CD8+ cells as well as by successful adoptive transfer of CD8+ T cells from TRMN-immunized mice to naive mice.